68 Hedge Funds Buy Valeant For The First Time
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reached 47.28% versus a 1-year low price of $8.31. The stock was last seen -4.6% lower, reaching at $12.24 on Tuesday, May 30, 2017. At recent session, the prices were hovering between $12.14 and $12.87. This company shares are -100% up from its target price of $0 and the current market capitalization stands at $4.16B.